Scientific AI Foundation Models Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 1.8 billion
Estimated Base Value
2035 Forecast
US$ 19.8 billion
Projected Market Value
CAGR 2026–2035
27.2%
Compound Annual Growth
Largest Segment
Generative Scientific AI Models
Fastest Growing Segment
Simulation AI Foundation Models
Leading Region
North America
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
33.5% market share
Key Players
Insilico Medicine
Emerging Players
Profluent, EvolutionaryScale
Market Definition & Overview
The Scientific AI Foundation Models Market encompasses the development, deployment, and utilization of large-scale, pre-trained artificial intelligence models specifically engineered for scientific research and discovery. These models leverage vast datasets from disciplines such as biology, chemistry, physics, materials science, and climate science to identify complex patterns, generate hypotheses, and predict outcomes. They serve as adaptable architectures for a multitude of scientific tasks, including drug discovery, materials design, protein folding, climate modeling, and complex system simulations, significantly accelerating the pace of scientific innovation. This market covers providers of these foundational models, related platforms, and specialized services enabling their scientific applications.
Scope
- Global market coverage across all major geographical regions
- Focus on enterprise, academic, and governmental research sectors
- Analysis of market dynamics and forecasts from 2023 to 2030
Inclusions
- Development and licensing of scientific AI foundation models
- Platforms for fine-tuning and deploying scientific foundation models
- Services for model customization and integration within scientific workflows
- Foundation models used in drug discovery and development
- Scientific AI models applied to materials science and engineering
- Climate modeling and environmental science applications using foundation models
Exclusions
- General-purpose AI foundation models without scientific domain specialization
- Traditional machine learning models not classified as foundation models
- AI solutions exclusively for business operations or consumer applications
- Generic cloud computing services for AI infrastructure
- Purely academic research without commercialization intent
Market Size Forecast
Executive Summary
• The Scientific AI Foundation Models market is valued at $1.8 Bn in 2025 and is forecast to reach $19.8 Bn by 2035, reflecting a robust CAGR of 27.2% as demand accelerates across every major segment and region over the ten-year outlook.
• Generative Scientific AI Models leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at 35.0%, while Emerging Areas is expanding the fastest at a 18.0% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 33.5% of global share, anchoring overall demand within its home region throughout the forecast period.
• The market is entering a pivotal consolidation phase, driven by incumbent tech giants acquiring specialized AI research firms to integrate advanced scientific modeling capabilities and expand their platform ecosystems across key regions.
• Accelerating R&D demands across pharmaceuticals, materials science, and climate modeling are key catalysts, pushing diverse industries toward scalable AI foundation models for complex predictive and generative tasks.
• Breakthroughs in multimodal data integration and explainable AI are poised to unlock unprecedented scientific discovery, necessitating significant investment in advanced computational infrastructure and specialized talent development.
• Strategic government funding in North America and Europe, coupled with escalating venture capital, is fueling rapid innovation and driving regional specialization in high-impact scientific AI applications.
• The intensifying race for critical compute resources and specialized scientific datasets highlights supply chain vulnerabilities, while emerging ethical AI guidelines introduce new regulatory complexities for deployment.
• Future growth hinges on fostering collaborative ecosystems between academia, industry, and government to address data interoperability challenges and accelerate the real-world impact of scientific AI.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The Scientific AI Foundation Models Market is valued at $1.8 billion in the base year.
Future Market Potential
Projections indicate the market for Scientific AI Foundation Models will reach $19.8 billion by the forecast year.
Robust Growth Outlook
The Scientific AI Foundation Models Market is poised for significant expansion, demonstrating a Compound Annual Growth Rate (CAGR) of 27.2%.
Significant Market Expansion
From its base year valuation of $1.8 billion, the Scientific AI Foundation Models Market is projected for nearly eleven-fold growth to $19.8 billion by the forecast year.
Driving Scientific Segments
Leading segments in the Scientific AI Foundation Models market are characterized by high-impact applications in areas such as drug discovery, materials science, and climate modeling.
Interdisciplinary Innovation Trend
A notable trend within this market is the increasing interdisciplinary collaboration and the integration of diverse data types to accelerate scientific breakthroughs.
Market Dynamics
Market Trends
- Growing demand for multimodal scientific data integration.
- Increasing focus on explainable and interpretable AI models.
- Rise of open-source initiatives for scientific foundation models.
- Expansion into new scientific domains like astrophysics.
Growth Drivers
- Vast amounts of scientific data require advanced analysis.
- Accelerating drug discovery and material design processes.
- Improvements in AI model architecture and computational power.
- Need for more efficient scientific research and development.
Restraints
- High computational costs limit broad access and development.
- Availability of high-quality, labeled scientific data remains a hurdle.
- Integrating deep domain expertise with AI models is complex.
- Ensuring model interpretability and trustworthiness is challenging.
Opportunities
- Developing AI for accelerated drug and vaccine discovery.
- Creating models for advanced climate and environmental predictions.
- Applying AI to precision agriculture and sustainable energy solutions.
- Building specialized foundation models for unique scientific domains.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Generative Scientific AI ModelsPredictive Scientific AI ModelsSimulation AI Foundation ModelsKnowledge Graph AI Foundation ModelsMultimodal Scientific AI ModelsDomain-Specific AI Foundation ModelsGeneral Scientific AI Foundation ModelsOthers |
| By Application | Drug Discovery & DevelopmentMaterials Science ResearchBiotechnology & GenomicsClimate Science & Environmental ModelingChemistry & ChemoinformaticsPhysics & Engineering SimulationMedical Imaging & DiagnosticsOthers |
| By End-User | Pharmaceutical & Biotech CompaniesAcademic & Research InstitutionsGovernment Research OrganizationsChemical & Advanced Materials IndustryEnergy & Environmental SectorHealthcare & Life Sciences ProvidersTechnology & Software DevelopersOthers |
| By Technology | Transformer ArchitecturesGenerative Adversarial NetworksVariational AutoencodersReinforcement Learning ModelsGraph Neural NetworksLarge Language Models for ScienceLarge Vision Models for ScienceOthers |
| By Deployment | Cloud-BasedOn-PremiseHybrid DeploymentEdge-BasedAPI-Based AccessSoftware as a ServicePlatform as a ServiceOthers |
| By Component | Pre-Trained Foundation ModelsModel Customization & Fine-Tuning ServicesData Curation & Preparation ToolsModel as a Service PlatformsDevelopment & Integration ToolsConsulting & Support ServicesTraining & Education ProgramsOthers |
Regional Analysis
- North America currently leads the Scientific AI Foundation Models market due to its robust ecosystem of tech giants, top-tier research universities, significant venture capital investments, and early adoption across various scientific domains. This fosters innovation and rapid development.
- Asia-Pacific is rapidly emerging as the fastest-growing region, driven by substantial government investments in AI research, a burgeoning talent pool, and increasing industry adoption, particularly in China and India, focusing on specific scientific applications.
- An emerging trend sees Europe focusing on developing scientific AI foundation models with a strong emphasis on ethical guidelines, data privacy, and explainability. This reflects regional regulatory priorities and aims to build trustworthy, responsible AI systems for scientific discovery.
Asia Pacific
15.0% CAGR
$0.5 Bn
30% share
- Characterized by rapid adoption and significant government funding, particularly in China, Japan, and South Korea.
- This region leverages vast datasets and a growing talent pool to advance scientific AI applications across diverse fields.
North America
12.5% CAGR
$0.6 Bn
35% share
- This region leads in foundational AI research and development, benefiting from strong private investment, robust academic-industry partnerships, and a high concentration of tech giants driving innovation in scientific AI.
Europe
11.0% CAGR
$0.4 Bn
22% share
- Europe boasts a strong academic research base and significant public funding for ethical AI development.
- Focus is on collaborative projects and applying AI to scientific challenges in healthcare, climate, and materials science, often within EU frameworks.
Latin America
14.0% CAGR
$0.1 Bn
6% share
- This region shows growing interest and investment in scientific AI, particularly for addressing local challenges in agriculture, biodiversity, and healthcare.
- Emerging research hubs and startups are contributing to steady market expansion.
Middle East & Africa
16.0% CAGR
$0.1 Bn
4% share
- Strategic national initiatives and significant state-backed investments are fueling the growth of scientific AI.
- Countries like UAE and Saudi Arabia are establishing advanced research centers, aiming to diversify economies and tackle regional scientific problems.
Emerging Areas
18.0% CAGR
$0.1 Bn
3% share
- Comprising smaller, nascent geographies, this segment is witnessing initial adoption driven by academic pilot projects and increasing connectivity.
- While currently small, it holds the highest growth potential from a lower base as infrastructure and awareness improve.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $0.6 Bn | 28.5% | The U.S. leads in Scientific AI Foundation Models due to its extensive network of top-tier research institutions, tech giants with dedicated AI labs, and significant government and private sector funding for advanced scientific computing. |
| 2 | Brazil | $0.0 Bn | 25.0% | Brazil, as Latin America's largest economy, has a significant scientific community and growing tech industry actively exploring AI applications in areas such as environmental science and health, contributing to foundation model research. |
| 3 | United Kingdom | $0.1 Bn | 29.0% | The UK is a global leader in AI research, home to prominent AI labs and universities, with substantial government and private investment accelerating the development of foundation models for scientific discovery and healthcare. |
| 4 | China | $0.3 Bn | 30.5% | China is making massive investments in AI R&D, with numerous tech giants and state-backed initiatives driving the creation of large-scale foundation models for scientific and industrial applications, aiming for global leadership. |
| 5 | Israel | $0.0 Bn | 34.0% | Israel is a global leader in AI startups and deep tech, known for its strong ecosystem and contributions to innovative AI solutions applicable to scientific research, especially in biotech and computational fields. |
Countries Covered (23)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, United Kingdom, Germany, France, Switzerland, Netherlands, Rest of Europe, China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia Pacific, Israel, United Arab Emirates, Saudi Arabia, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Insilico Medicine | 5.7% | Utilize an end-to-end AI platform to accelerate drug discovery and development from target identification to clinical trials. | Pioneered the advancement of an AI-discovered, AI-designed drug candidate into human clinical trials. | Advanced its lead drug candidate for idiopathic pulmonary fibrosis (INS018_055) into Phase II clinical trials. | Pharma.AIGenerative ChemistryGenerative Biology+1 |
| 2 | Generate Biomedicines | 5.4% | Leverage a machine learning platform to program novel protein therapeutics across various modalities and diseases. | Focuses on a 'full-stack' approach to design functional proteins from scratch using AI. | Secured a significant multi-target partnership with Amgen for AI-driven discovery and development of protein therapeutics. | The Generate PlatformGenerative Protein DesignAI-enabled Drug Discovery |
| 3 | Recursion Pharmaceuticals | 5.1% | Integrate robotic automation, high-throughput wet-lab experiments, and AI to map human biology and accelerate drug discovery. | Publicly traded company building a massive dataset of biological images and data for drug discovery. | Announced a major strategic partnership with NVIDIA to accelerate AI model training for drug discovery. | Recursion OSPhenomic AIDigital Biology Platform |
| 4 | Exscientia | 4.9% | Design novel drugs from scratch using AI, optimizing for specific patient populations and accelerating the discovery timeline. | Credited with advancing the first AI-designed drug into human clinical trials. | Entered a clinical trial collaboration with the MD Anderson Cancer Center for AI-driven drug development in oncology. | AI Drug Discovery PlatformPrecision Medicine PlatformEXSCALATE |
| 5 | Schrödinger | 4.6% | Provide a physics-based computational platform and software solutions to accelerate drug discovery and materials science research. | Offers established software solutions in computational chemistry and biology, integral to modern drug design workflows. | Expanded its strategic drug discovery collaboration with Sanofi to include multiple targets across different therapeutic areas. | MaestroFEP+LiveDesign+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Insilico Medicine, Generate Biomedicines, Recursion Pharmaceuticals, Exscientia, Schrödinger, Insitro, AbCellera, BenevolentAI, Hugging Face, Tempus AI, Owkin, Convexity Scientific, Terray Therapeutics, PostEra, Deep Genomics, Enveda Biosciences, LabGenius, Acellera, Stability AI, OpenAI
The global Scientific AI Foundation Models market features a competitive landscape led by Insilico Medicine, Generate Biomedicines, Recursion Pharmaceuticals, Exscientia, Schrödinger, and Insitro, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Insilico Medicine
Generate Biomedicines
Recursion Pharmaceuticals
Exscientia
Schrödinger
Insitro
AbCellera
BenevolentAI
Hugging Face
Tempus AI
Owkin
Convexity Scientific
Terray Therapeutics
PostEra
Deep Genomics
Enveda Biosciences
LabGenius
Acellera
Stability AI
OpenAI
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
DeepMind Unveils 'BioFathom' for Advanced Protein Prediction
Google DeepMind launched BioFathom, an advanced AI foundation model designed to revolutionize protein structure and function prediction, offering unprecedented accuracy and speed for pharmaceutical and biotech research. This model is expected to significantly accelerate drug discovery and understanding of biological processes.
Materials AI Startup 'Atomica' Secures $100M Series B Funding
Atomica, a leading startup developing scientific foundation models for accelerated material discovery and design, announced a successful $100 million Series B funding round led by Andromeda Ventures. The investment will fuel the expansion of their proprietary models and HPC infrastructure, aiming to unlock breakthroughs in renewable energy and advanced manufacturing.
IBM Research Partners with NOAA for Climate AI Models
IBM Research and the National Oceanic and Atmospheric Administration (NOAA) announced a strategic partnership to develop and deploy cutting-edge AI foundation models to enhance global climate prediction and extreme weather forecasting accuracy. This collaboration aims to leverage IBM's AI expertise with NOAA's vast meteorological data.
CERN Activates Exascale AI Cluster for Fundamental Physics
CERN announced the activation of its new exascale AI computing cluster, purpose-built to train and deploy scientific foundation models for particle physics and cosmology. This significant infrastructure expansion provides unparalleled computational power, accelerating discoveries in fundamental science and data analysis from experiments like the LHC.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $1.8 Bn |
| Market Size (Forecast) | $19.8 Bn |
| CAGR | 27.2% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 23 Countries |
| Segments Covered | 6 Segments, 48 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included